chr21-26845001-C-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006988.5(ADAMTS1):c.-47G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 34)
Exomes 𝑓: 7.5e-7 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ADAMTS1
NM_006988.5 5_prime_UTR
NM_006988.5 5_prime_UTR
Scores
1
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.123
Publications
18 publications found
Genes affected
ADAMTS1 (HGNC:217): (ADAM metallopeptidase with thrombospondin type 1 motif 1) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motif) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene contains two disintegrin loops and three C-terminal TS motifs and has anti-angiogenic activity. The expression of this gene may be associated with various inflammatory processes as well as development of cancer cachexia. This gene is likely to be necessary for normal growth, fertility, and organ morphology and function. [provided by RefSeq, Jul 2008]
ADAMTS1 Gene-Disease associations (from GenCC):
- autosomal dominant prognathismInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 genomes
Cov.:
34
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.54e-7 AC: 1AN: 1326102Hom.: 0 Cov.: 47 AF XY: 0.00000155 AC XY: 1AN XY: 646118 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1326102
Hom.:
Cov.:
47
AF XY:
AC XY:
1
AN XY:
646118
show subpopulations
African (AFR)
AF:
AC:
0
AN:
28692
American (AMR)
AF:
AC:
0
AN:
27740
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
19120
East Asian (EAS)
AF:
AC:
0
AN:
37632
South Asian (SAS)
AF:
AC:
0
AN:
64918
European-Finnish (FIN)
AF:
AC:
1
AN:
36768
Middle Eastern (MID)
AF:
AC:
0
AN:
5198
European-Non Finnish (NFE)
AF:
AC:
0
AN:
1051104
Other (OTH)
AF:
AC:
0
AN:
54930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome Cov.: 34
GnomAD4 genome
Cov.:
34
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Uncertain
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.